Cite
MLA Citation
Milind Javle et al.. “Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.” Lancet oncology, vol. 22, no. 9, 2021, pp. 1290–1300. http://access.bl.uk/ark:/81055/vdc_100144484585.0x00002e